BSE: ZYDUSLIFE - Zydus Lifesciences Limited

Rentabilidad a seis meses: -8.83%
Sector: Healthcare

Calendario de promoción Zydus Lifesciences Limited


Acerca de la empresa

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments.

más detalles
It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, dermatology, liver diseases, and other areas. The company also provides consumer wellness products, such as Complan; EverYuth, a range of skincare products; Nycil; Glucon-D glucose powder; Nutralite; Nutralite Doodhshakti, a portfolio of dairy products; and various other products. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, ophthalmology, inflammation, rheumatology, hepatology, infectious disease, etc. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is based in Ahmedabad, India.

EBITDA 25.16
EV/EBITDA 14.03
ISIN INE010B01027
Industry Pharmaceuticals
P/BV 2.4
P/E 23.93
P/S 2.04
Sector Health Care
Валюта inr
Валюта отчета inr
Выручка 138.12
Див.доход ао 1.34
Дивиденд ао 6
Сайт https://zyduslife.com
Цена ао 1054.35
Число акций ао 1.0122 млрд
Cambio de precio por día: +1.37% (959.55)
Cambio de precio por semana.: -0.1232% (973.9)
Cambio de precio por mes: +2.31% (950.7)
Cambio de precio en 3 meses.: -9.48% (1074.6)
Cambio de precio en seis meses: -8.83% (1066.95)
Cambio de precio por año: +41.75% (686.2)
Cambio de precio en 3 años.: +119.03% (444.1)
Cambio de precio en 5 años.: +332.98% (224.65)
Cambio de precio en 10 años.: 0% (972.7)
Cambio de precio desde principios de año.: -1.55% (988)

Subestimación

Nombre Significado Calificación
P/S 5.29 2
P/BV 4.55 3
P/E 26.06 6
EV/EBITDA 14.65 7
Total: 5

Eficiencia

Nombre Significado Calificación
ROA, % 14.03 4
ROE, % 20.67 7
Total: 4.17

Dividendos

Nombre Significado Calificación
Div yield, % 0.7249 1.8
DSI 0.8571 8.57
Total: 2.58

Deber

Nombre Significado Calificación
Debt/EBITDA 0 10
Total: 10

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 37.72 5
Rentabilidad Ebitda, % 36.84 5
Rentabilidad EPS, % 233.73 10
Total: 7.2



Supervisor Título profesional Pago año de nacimiento
Dr. Sharvil Pankajbhai Patel MD & Executive Director 262.5M 1979 (46 años)
Dr. Ganesh Narayan Nayak COO & Executive Director 120M 1955 (70 años)
Mr. Punit Patel President & CEO of America N/A
Mr. Nitinkumar Dalsukhray Parekh Chief Financial Officer 54.31M
Mr. Arvind Bothra Head of Investor Relations N/A
Mr. Dhaval Narendra Soni Company Secretary & Compliance Officer 2.09M

DIRECCIÓN: India, Ahmedabad, Zydus Corporate Park - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://zyduslife.com